Justin West is a physician and father of three. His youngest son, Andrew, was diagnosed with KCNT1-related epilepsy at 9 months of age. He is director of clinical medicine at the KCNT1 Epilepsy Foundation, working with researchers and industry to identify and evaluate potential therapeutics.
Justin West
President and director of clinical medicine
KCNT1 Epilepsy Foundation
From this contributor
Progress amid setbacks in drug trials for rare forms of epilepsy: Q&A with Justin West
Despite grave side effects, it’s vital to keep developing treatments for rare genetic forms of childhood epilepsy, says West, president of the KCNT1 Epilepsy Foundation and father of a son with the condition.
Progress amid setbacks in drug trials for rare forms of epilepsy: Q&A with Justin West
Explore more from The Transmitter
Five-year-old human brain organoids aged on schedule
The cultured spheres typically mimic only prenatal development, but the five-year-old ones grown in Paola Arlotta’s lab acquired postnatal features.
Five-year-old human brain organoids aged on schedule
The cultured spheres typically mimic only prenatal development, but the five-year-old ones grown in Paola Arlotta’s lab acquired postnatal features.
Marco Facchin explores the ever-shifting landscape of neuroscience theory and philosophy
Computational explanations of cognition, though powerful, aren't the only game in town.
Marco Facchin explores the ever-shifting landscape of neuroscience theory and philosophy
Computational explanations of cognition, though powerful, aren't the only game in town.
Brainstem neurons add new element to ‘already complex’ anxiety circuitry
Precise optogenetic modulation of a medullary neuron population reveals their role in anxiety-like behaviors.
Brainstem neurons add new element to ‘already complex’ anxiety circuitry
Precise optogenetic modulation of a medullary neuron population reveals their role in anxiety-like behaviors.